𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Allelic frequencies of HPA-1 to 5 human platelet antigens in patients infected with hepatitis C virus

✍ Scribed by Camila Fernanda Verdichio-Moraes; Cecília Toralles-Pereira; Rejane Maria Tommasini Grotto; Giovanni Faria Silva; Maria Inês de Moura Campos Pardini


Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
60 KB
Volume
81
Category
Article
ISSN
0146-6615

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Studies have suggested that hepatitis C virus (HCV) may infect not only hepatocytes but may also be carried by platelets. Platelets express more than 20 polymorphic antigenic determinants on their surface, which are called human platelet antigens (HPA). To determine the allele frequency of the HPA‐1 to ‐5 in patients infected with HCV, blood samples were collected from 257 blood donors for the control group and from 191 patients infected with HCV. DNA was isolated and amplified for genes HPA‐1 to ‐4 using PCR Sequence Specific Primers (PCR‐SSP) and HPA‐5 using PCR‐Restriction Fragment Length Polymorphism (PCR‐RFLP). The allelic and genotypic frequency of HPA‐5a in patients infected with HCV was found to be significantly lower (P < 0.05) than in the controls, and HPA‐5b from patients infected with HCV was significantly higher (P < 0.05) than in controls. The increase in HPA‐5b allelic frequency in HCV infection may indicate a possible association between HCV infection and HPAs. J. Med. Virol. 81:757–759, 2009 © 2009 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


Predictors of viral kinetics to peginter
✍ Norio Akuta; Fumitaka Suzuki; Yusuke Kawamura; Hiromi Yatsuji; Hitomi Sezaki; Yo 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 134 KB 👁 1 views

## Abstract For chronic hepatitis C virus (HCV) infection, evaluation of response to peginterferon (PEG‐IFN) plus ribavirin (RBV) therapy based on viral kinetics is useful as an early predictor of treatment efficacy, but the underlying mechanisms of the different viral kinetics to treatment are sti

Mutations in the NS5A gene of hepatitis
✍ Hofgärtner, Wolfgang T.; Polyak, Stephen J.; Sullivan, Daniel G.; Carithers, Rob 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 310 KB 👁 3 views

Previous studies from Japan have described an association between a conserved sequence within the hepatitis C virus (HCV) genome and resistance to interferon (IFN) therapy for patients infected with HCV genotype 1b [

Mutations in the nonstructural protein 5
✍ Komatsu, Haruki; Fujisawa, Tomoo; Inui, Ayano; Miyagawa, Yoshihiro; Onoue, Masah 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 38 KB 👁 3 views

A region associated with sensitivity to interferon (IFN) has been identified previously in the nonstructural protein 5A (NS5A) of hepatitis C virus (HCV) genotype 1b. A study was undertaken to determine whether the presence of mutations in the NS5A 2209-2248 sequence could serve as a predictor of re

Prediction of response to peginterferon-
✍ Yoshimasa Hashimoto; Hidenori Ochi; Hiromi Abe; Yasufumi Hayashida; Masataka Tsu 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 174 KB 👁 1 views

## Abstract Variation at the IL‐28B locus was recently reported to be a significant predictive factor of viral response to pegylated‐interferon plus ribavirin combination therapy against chronic hepatitis C. Predictive factors for the effect of therapy, including IL‐28B polymorphism rs8099917 and v

Mutations in the E2 and NS5A regions in
✍ Neda Yahoo; Farzaneh Sabahi; Kiana Shahzamani; Mohamad Ali Malboobi; Hossain Jab 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 288 KB 👁 2 views

## Abstract Heterogeneity of subgenomic regions of hepatitis C virus (HCV) may be associated with response to interferon (IFN) therapy. The amino acid sequences of the PKR/eIF‐2α phosphorylation homology domain (pePHD), IFN sensitivity determining region (ISDR), PKR binding domain (PKRBD), and vari

Multiple ascending dose study of BMS-790
✍ Richard E. Nettles; Min Gao; Marc Bifano; Ellen Chung; Anna Persson; Thomas C. M 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 282 KB

Abbreviations: AE, adverse event; AUC, area under the plasma concentration time curve; AUC (TAU) , AUC over 12-hour dosing interval for 30 mg twice daily; C min , minimum observed plasma concentration; C max , maximum observed plasma concentration; C trough , trough concentrations; CLT/F, apparent t